← Open Payments lookup

KATHERINE MOORE: Open Payments

NPI 1740834316 · WILMINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$793 in 49 payments from 10 companies in 2025. Trend: 2023 $1,275 · 2024 $1,785 · 2025 $793

Food & beverage: $793
CompanyPaymentsAmount
Madrigal Pharmaceuticals6$254
ABBVIE INC.19$209
Novo Nordisk Inc13$147
Janssen Biotech, Inc.2$46
Phathom Pharmaceuticals, Inc.3$39
Takeda Pharmaceuticals U.S.A., Inc.2$34
Boehringer Ingelheim Pharmaceuticals, Inc.1$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17
Lilly USA, LLC1$14
Amgen Inc.1$14

Products named: REZDIFFRA, Ozempic, SKYRIZI, QULIPTA, TREMFYA, UBRELVY, VOQUEZNA, ENTYVIO.

Industry payments across OH — which companies pay providers there.